TABLE 2.
Groups |
Subgroup A (1 mo) |
Subgroup B (2 mo) |
Subgroup C (3 mo) |
P‐value | |||
---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | ||
Group I (blood clot) |
0.26aA (8%) |
0.07 |
0.31bA (9.5%) |
0.05 |
0.35cA (10.7%) |
0.06 | ≤.001* |
Group II (EDTA + blood clot) |
0.30aAB (9.2%) |
0.07 |
0.34bAB (10.4%) |
0.06 |
0.37cA (11.35%) |
0.08 | ≤.001* |
Group III (PRF) |
0.32aAB (9.6%) |
0.04 |
0.38bBC (12.16%) |
0.07 |
0.44cB (14.1%) |
0.06 | ≤.001* |
Group IV (EDTA + PRF) |
0.34aB (10.1%) |
0.05 |
0.43bC (12.7%) |
0.09 |
0.50cC (14.9%) |
0.08 | ≤.001* |
Group V (positive control) |
0.00 | 0.00 | 0.00 | ||||
Group VI (negative control) |
0.43aC (12.7%) |
0.08 |
0.51bD (15.7%) |
0.08 |
0.58cD (17.96%) |
0.05 | .003* |
P‐value | ≤0.001* | ≤0.001* | ≤0.001* |
The same upper‐case letters within each column indicate differences that were not significant.
The same lower‐case letters within each row indicate differences that were not significants.
Abbreviation: NS, not significant.
Significant at P ≤ .05.